GeneTex
United States (US)

NAP2 recombinant protein

Cat No. GTX65205

Application ELISA, Functional Assay, Apuri, Blocking
Reactivity Human
Species Human
APPLICATION

Application Note

Protein's bioactivity determined by its ability to chemoattract human neutrophils using a concentration range of 1.0-10 ng/ml.

Calculated MW

7.6 kDa. ( Note )
PROPERTIES

Form

Lyophilized powder

Storage

Reconstitute in water to a concentration of 0.1-1.0 mg/ml. This solution can then be diluted into other aqueous buffers and stored at 4ºC for 1 week or –20º for future use.

Antigen Species

Human

Expression System

E. coli

Purification


Purity was assessed by SDS-PAGE (≥98%) and by HPLC (≥98%).

Note

For laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
TARGET

Synonyms

Macrophagederived growth factor, Leukocytederived growth factor, pro-platelet basic protein (chemokine (C-X-C motif) ligand 7), B-TG1, TGB, Platelet basic protein, LA-PF4, NAP2, SCYB7, LAPF4, Sm, CXCL7, BTG1, Macrophage-derived growth factor, CTAP3, proplatelet basic protein (chemokine (CXC motif) ligand7), MDGF, Leukocyte-derived growth factor, B TG1, LA PF4

Background

Human Neutrophil activating protein-2 (NAP-2) promotes neutrophil chemotaxis and degranulation. Recombinant human NAP-2 is a 7.6 kDa protein containing 70 amino acid residues.
Package List Price ($)
$ 249